68216人已查看 《JOURNAL OF MEDICINAL CHEMISTRY》 期刊2024最新IF预测值
预警说明查看说明
时间
预警情况
2024年02月发布的2024版
不在预警名单中
2023年01月发布的2023版
不在预警名单中
2021年12月发布的2021版
不在预警名单中
2020年12月发布的2020版
不在预警名单中
2025年预警名单预测
无异常数据 期刊预警概率很低
结果仅供参考
*来源:中科院《 国际期刊预警名单》
中科院分区查看说明
版本
大类学科
小类学科
Top期刊
综述期刊
2023年12月最新升级版
医学1区
CHEMISTRY, MEDICINAL
药物化学
1区
是
否
2022年12月升级版
医学1区
CHEMISTRY, MEDICINAL
药物化学
1区
是
否
2021年12月升级版
医学2区
CHEMISTRY, MEDICINAL
药物化学
1区
是
否
2021年12月升级版
医学1区
CHEMISTRY, MEDICINAL
药物化学
1区
是
否
2020年12月升级版
医学1区
CHEMISTRY, MEDICINAL
药物化学
1区
是
否
JCR分区
WOS分区等级:Q1区
版本
按学科
分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of
Science)为每个学科内的期刊按照IF数值排序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2022-2023年最新版)
CHEMISTRY, MEDICINAL
Q1
测一测你投这本期刊的成功率
【官方推荐】国内首个期刊投稿预测系统,多维度分析投稿成功率,助你精准决策
12481
人已预测
期刊介绍
The Journal of Medicinal Chemistry发表分子结构与生物活性或作用模式之间关系的相关研究。The Journal of Medicinal Chemistry publishes studies that contribute to an understanding of the relationship between molecular structure and biological activity or mode of action.Some specific areas that are appropriate include the following:Design, synthesis, and biological evaluation of novel biologically active compounds, diagnostic agents, or labeled ligands employed as pharmacological tools.Molecular modifications of reported series that lead to a significantly improved understanding of their structure-activity relationships (SAR). Routine extensions of existing series that do not utilize novel chemical or biological approaches or do not add significantly to a basic understanding of the SAR of the series will normally not be accepted for publication.Structural biological studies (X-ray, NMR, etc.) of relevant ligands and targets with the aim of investigating molecular recognition processes in the action of biologically active compounds.Molecular biological studies (e.g., site-directed mutagenesis) of macromolecular targets that lead to an improved understanding of molecular recognition.Computational studies that provide fresh insight into the SAR of compound series that are of current general interest or analysis of other available data that subsequently advance medicinal chemistry knowledge.Substantially novel computational chemistry methods with demonstrated value for the identification, optimization, or target interaction analysis of bioactive molecules.Effect of molecular structure on the distribution, pharmacokinetics, and metabolic transformation of biologically active compounds. This may include design, synthesis, and evaluation of novel types of prodrugs.Novel methodology with broad application to medicinal chemistry, but only if the methods have been tested on relevant molecules.
Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER).
来源期刊:Journal of medicinal chemistry
DOI:10.1021/ACS.JMEDCHEM.8B01572
Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects.
来源期刊:Journal of medicinal chemistry
DOI:10.1021/acs.jmedchem.8b01210
Novel Allosteric Activators for Ferroptosis Regulator Glutathione Peroxidase 4.
来源期刊:Journal of medicinal chemistry
DOI:10.1021/acs.jmedchem.8b00315
A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity.
来源期刊:Journal of medicinal chemistry
DOI:10.1021/acs.jmedchem.9b00723
Antimicrobial Peptides with High Proteolytic Resistance for Combating Gram-Negative Bacteria.